Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Evonetix
Evonetix
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part II
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials
Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer
Denis will be responsible for optimising global operations for the company
SeaBeLife awarded over €1.5 million in i-Nov innovation competition
Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Evonetix delivers chip-synthesised DNA to the University of Cambridge
The DNA was delivered to Dr Jenny Molloy, Co-chair of the Engineering Biology Interdisciplinary Research Centre at the University of Cambridge
Evonetix attains DNA synthesis patent
The company’s approach to parallel DNA synthesis is underpinned by independent control of temperature at thousands of individual synthesis sites across the surface of a silicon chip
Ingredients
Evonetix achieves enzymatic DNA synthesis
Dr Raquel Sanches-Kuiper, VP of Technology at Evonetix, directed the research
Regulatory
Evonetix granted patent for DNA data storage tech
The company’s DNA-on-chip platform uses individually controlled ‘virtual wells’ to enable either de-novo DNA synthesis or immobilisation of pre-synthesised DNA for storage in-situ
Research & Development
Evonetix and Analog Devices collaborate on DNA synthesis platform
The two companies began working together in January 2019
Manufacturing
Synthetic biology company moves to Cambridge business park in the UK
UK-based gene synthesis specialist Evonetix is developing a desktop DNA synthesis platform based on a proprietary silicon chip
Manufacturing
Evonetix partner with LioniX to enable DNA synthesis at scale
Silicon processing techniques will be used to manufacture a silicon array using synergistic thermal control chemistry to deliver high-throughput assembly of high-fidelity gene-length DNA
Subscribe now